Optimizing the Consent Process for Emergent Laparoscopic Cholecystectomy
1 other identifier
interventional
79
1 country
1
Brief Summary
The Canadian Medical Protective Association (CMPA) defines informed consent (IC) as a voluntary process where important elements include details of the procedure, complications, and proposed alternatives. Laparoscopic cholecystectomy (LC) was the most common laparoscopic procedure cited in 423 medical-legal cases reported by CMPA in 2017, with 29% of cases citing issues in pre-operative care including inadequacy of the consent process. The investigators recently demonstrated that technology can help improve the IC process in an outpatient setting by conducting a prospective randomized controlled trial to examine the effects of adding a digital educational platform (DEP) module to a standard verbal consent (SVC) for an elective laparoscopic Roux-en-Y gastric bypass procedure. The investigators demonstrated a significant improvement in immediate post-consent knowledge of the risks, benefits and alternatives in patients who viewed the DEP module with equivalent patient satisfaction as compared to a SVC. With the proposed study the investigators plan to gather evidence to support implementing a digital education platform for emergent surgical procedures performed in an in-patient setting. The investigators propose to conduct a randomized controlled trial to explore the benefits of adding a DEP module to a SVC for patients presenting with acute cholecystitis requiring an emergent LC as an in-patient. Participants will be randomly allocated (1:1) to either a control group (SVC) or an intervention group (SVC + DEP). Primary outcome of interest will be immediate post-consent knowledge of the risks, benefits, alternatives and expected outcomes for a LC. Secondary outcomes will include satisfaction with the consent discussion and delayed retention of knowledge of the risks, benefits, alternatives and expected outcomes for a LC . The investigators hypothesize that completion of the DEP module in addition to SVC will result in superior immediate and delayed post-consent knowledge of risks and benefits of LC with equivalent patients satisfaction as compared to SVC alone. The results of this study will provide evidence supporting the addition of DEP to SVC for urgent and emergent surgical procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2021
CompletedFirst Posted
Study publicly available on registry
April 21, 2021
CompletedStudy Start
First participant enrolled
September 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedApril 3, 2024
April 1, 2024
1.9 years
April 15, 2021
April 2, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Knowledge of the Laparoscopic Cholecystectomy Procedure
Understanding indications for surgery, alternatives, risks, complications, expectations and anticipated recovery will be one of the primary outcomes for this study. A 20 question multiple choice questionnaire will be used to measure this outcome.
1 day
Secondary Outcomes (3)
Self-reported rating of understanding of the laparoscopic cholecystectomy procedure.
1 day
Retention of Knowledge
4-6 weeks
Participant satisfaction with the clinical encounter
1 day
Study Arms (2)
Digital Educational Platform
EXPERIMENTALStudy participants randomized to the DEP+SVC group (intervention) will be presented with an iPad with a link to an interactive DEP module discussing the indications for LC, alternatives, risks, complications, expectations and anticipated recovery. They will be asked to review the DEP module at their own pace and will be required to confirm understanding of all of the material presented on the DEP. Upon completion of the module, a member of the surgery team will ask the patient if they have any additional questions or require further clarification regarding the LC procedure, indications for surgery, alternatives, risk, complications, expectations and anticipated recovery. Once all of participant's questions are answered, an informed paper-based consent form for LC will be signed.
Standard Verbal Consent
ACTIVE COMPARATORStudy participants randomized to the SVC group (control) will discuss the LC procedure, indications for surgery, alternatives, risk, complications, expectations and anticipated recovery with a member of the surgery team. The study participant will be given the opportunity to ask questions and once all of the questions have been answered, an informed paper-based consent form for LC will be signed.
Interventions
In-patients being consented for laparoscopic cholecystectomy will be provided with a Digital Educational Platform (DEP), in the form of modules on an iPad. These participants will still undergo the usual standard verbal consent (SVC). Multiple choice questionnaires will be given pre and post consent to determine acquisition and retention of the information provided using DEP.
In-patients being consented for laparoscopic cholecystectomy will go through the SVC. Multiple choice questionnaires will be given pre and post consent to determine acquisition and retention of the information provided using SVC.
Eligibility Criteria
You may qualify if:
- Must be 18 years of age or older
- Individuals admitted to Kingston Health Sciences Centre with acute cholecystitis
- Must be able to read, write and speak English
- Must be able to provide consent
You may not qualify if:
- Individuals who are not able to provide informed consent for laparoscopic cholecystectomy.
- Individuals who are not able to access and view the interactive digital education platform
- Individuals who can not read, write or speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dr. Boris Zevinlead
Study Sites (1)
Queen's University
Kingston, Ontario, K7L4V1, Canada
Related Publications (1)
Zevin B, Almakky M, Mancini U, Robertson DI. Digital approach to informed consent in bariatric surgery: a randomized controlled trial. Surg Endosc. 2022 Jan;36(1):809-816. doi: 10.1007/s00464-020-08277-x. Epub 2021 Jan 27.
PMID: 33502615BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Boris Zevin
Queen's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Surgery
Study Record Dates
First Submitted
April 15, 2021
First Posted
April 21, 2021
Study Start
September 21, 2021
Primary Completion
July 31, 2023
Study Completion
September 30, 2023
Last Updated
April 3, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share